Cytokine Immunopathogenesis of Enterovirus 71 Brain Stem Encephalitis

Enterovirus 71 (EV71) is one of the most important causes of herpangina and hand, foot, and mouth disease. It can also cause severe complications of the central nervous system (CNS). Brain stem encephalitis with pulmonary edema is the severe complication that can lead to death. EV71 replicates in leukocytes, endothelial cells, and dendritic cells resulting in the production of immune and inflammatory mediators that shape innate and acquired immune responses and the complications of disease. Cytokines, as a part of innate immunity, favor the development of antiviral and Th1 immune responses. Cytokines and chemokines play an important role in the pathogenesis EV71 brain stem encephalitis. Both the CNS and the systemic inflammatory responses to infection play important, but distinctly different, roles in the pathogenesis of EV71 pulmonary edema. Administration of intravenous immunoglobulin and milrinone, a phosphodiesterase inhibitor, has been shown to modulate inflammation, to reduce sympathetic overactivity, and to improve survival in patients with EV71 autonomic nervous system dysregulation and pulmonary edema.

[1]  Jia Jun Lee,et al.  A Non-Mouse-Adapted Enterovirus 71 (EV71) Strain Exhibits Neurotropism, Causing Neurological Manifestations in a Novel Mouse Model of EV71 Infection , 2011, Journal of Virology.

[2]  H. Lei,et al.  Exogenous interleukin-6, interleukin-13, and interferon-gamma provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice , 2011, Respiratory research.

[3]  H. Lei,et al.  Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  S. Trasti,et al.  Sustained High Levels of Interleukin-6 Contribute to the Pathogenesis of Enterovirus 71 in a Neonate Mouse Model , 2011, Journal of Virology.

[5]  I. Elovaara,et al.  Can we face the challenge of expanding use of intravenous immunoglobulin in neurology? , 2010, Acta neurologica Scandinavica.

[6]  W. Gong,et al.  Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. , 2010, International immunopharmacology.

[7]  C. Brightling,et al.  Interleukin‐13: prospects for new treatments , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  Shainn-Wei Wang,et al.  Enterovirus 71 Infection of Human Dendritic Cells , 2009, Experimental biology and medicine.

[9]  Ching-Chuan Liu,et al.  Enterovirus 71: epidemiology, pathogenesis and management , 2009, Expert review of anti-infective therapy.

[10]  M. Shimojima,et al.  Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71 , 2009, Nature Medicine.

[11]  J. Bergelson,et al.  Receptors identified for hand, foot and mouth virus , 2009, Nature Medicine.

[12]  Jen-Ren Wang,et al.  Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. , 2008, The Journal of infectious diseases.

[13]  Ching-Chuan Liu,et al.  Enterovirus 71, one virus and many stories. , 2008, Pediatrics and neonatology.

[14]  Yee‐Shin Lin,et al.  The severity of Streptococcus pyogenes infections in children is significantly associated with plasma levels of inflammatory cytokines. , 2008, Diagnostic microbiology and infectious disease.

[15]  I. Su Perspectives on the pathogenesis and therapy of hemophagocytic syndrome. , 2008, Journal of the Formosan Medical Association = Taiwan yi zhi.

[16]  Marcus Müller,et al.  Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN‐γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro , 2007, Glia.

[17]  H. Lei,et al.  Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  Ali Danesh,et al.  Human immunopathogenesis of severe acute respiratory syndrome (SARS) , 2007, Virus Research.

[19]  Mei-Chih Huang,et al.  Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[20]  H. Lei,et al.  Type I interferons protect mice against enterovirus 71 infection. , 2005, The Journal of general virology.

[21]  Jen-Ren Wang,et al.  Therapeutic efficacy of milrinone in the management of enterovirus 71‐induced pulmonary edema , 2005, Pediatric pulmonology.

[22]  H. Hirasawa,et al.  Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. , 2005, Cytokine.

[23]  S. Moochhala,et al.  Chemokines in acute respiratory distress syndrome , 2005, American journal of physiology. Lung cellular and molecular physiology.

[24]  M. Wills-Karp,et al.  Interleukin‐13 in asthma pathogenesis , 2004, Immunological reviews.

[25]  I. Meza,et al.  IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. , 2004, The Journal of general virology.

[26]  Y. Hsu,et al.  Mechanism of Fulminant Pulmonary Edema Caused by Enterovirus 71 , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  U. V. von Andrian,et al.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.

[28]  M. Hosoya,et al.  Cytokine and cellular inflammatory sequence in enteroviral meningitis. , 2003, Pediatrics.

[29]  Jen-Ren Wang,et al.  Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. , 2003, The Journal of infectious diseases.

[30]  Yhu-Chering Huang,et al.  Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  J. Weiss,et al.  Alteration of Locus coeruleus Neuronal Activity by Interleukin-1 and the Involvement of Endogenous Corticotropin-Releasing Hormone , 2002, Neuroimmunomodulation.

[32]  J. Kellum,et al.  Blood purification in sepsis: an idea whose time has come? , 2002, Critical care medicine.

[33]  L. Chang,et al.  Different proinflammatory reactions in fatal and non‐fatal enterovirus 71 infections: implications for early recognition and therapy , 2002, Acta paediatrica.

[34]  C. Chiu,et al.  The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  P. McMinn An overview of the evolution of enterovirus 71 and its clinical and public health significance. , 2002, FEMS microbiology reviews.

[36]  J. Colinge,et al.  MIG—differential gene expression in mouse brain endothelial cells , 2002, Neuroreport.

[37]  G. Haskó Receptor-Mediated Interaction Between the Sympathetic Nervous System and Immune System in Inflammation , 2001, Neurochemical Research.

[38]  C. Samuel,et al.  Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.

[39]  Y. S. Lin,et al.  Immunopathogenesis of dengue virus infection. , 2001, Journal of biomedical science.

[40]  N. Takamatsu,et al.  Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change. , 2000, Journal of the American College of Cardiology.

[41]  Y. Nomura,et al.  Electrical stimulation of afferent vagus nerve induces IL-1beta expression in the brain and activates HPA axis. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[42]  E. Ongini,et al.  Interleukin‐10 modulates neuronal threshold of vulnerability to ischaemic damage , 2000, The European journal of neuroscience.

[43]  C. Biron,et al.  A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. , 2000, The Journal of clinical investigation.

[44]  J. Wang,et al.  Enterovirus infections with special reference to enterovirus 71. , 2000, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[45]  W. Karpus,et al.  Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. , 1999, Journal of neurovirology.

[46]  Shin-Ru Shih,et al.  Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease , 1999, The Lancet.

[47]  S. Chihara,et al.  Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass. , 1999, The Annals of thoracic surgery.

[48]  T. Yeh,et al.  Neurologic complications in children with enterovirus 71 infection. , 1999, The New England journal of medicine.

[49]  Kow-Tong Chen,et al.  An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. , 1999, The New England journal of medicine.

[50]  M. Corada,et al.  Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  T. Yeh,et al.  Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  W. Doyle,et al.  Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. , 1999, The Journal of infectious diseases.

[53]  K. Spanaus,et al.  Chemokines and chemotaxis of leukocytes in infectious meningitis , 1998, Journal of Neuroimmunology.

[54]  C. Dinarello,et al.  Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. , 1997, Chest.

[55]  R. Swinford,et al.  Dialysis membrane adsorption during CRRT. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[56]  I. Campbell,et al.  Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis , 1997, Journal of virology.

[57]  M. Hess,et al.  Milrinone: basic and clinical pharmacology and acute and chronic management. , 1996, The American journal of the medical sciences.

[58]  M. Levin,et al.  Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  A. Nakane,et al.  Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice , 1995, Infection and immunity.

[60]  K. Kristensson,et al.  Neuronal interferon‐γ immunoreactive molecule: Bioactivities and purification , 1994 .

[61]  K. Matsushima,et al.  Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 , 1993, Nature.

[62]  H. Kolb,et al.  IL-1 and IFN-gamma increase vascular permeability. , 1988, Immunology.

[63]  Mohammad Wahid Ansari,et al.  The legal status of in vitro embryos , 2014 .

[64]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[65]  J. D. de Vries The role of IL-13 and its receptor in allergy and inflammatory responses. , 1998, The Journal of allergy and clinical immunology.

[66]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[67]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[68]  T. Standiford,et al.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. , 1991, Experimental lung research.